- Home
- MGRC vs ARWR Comparison
MGRC vs ARWR Comparison
Compare MGRC & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRC
- ARWR
- Stock Information
- Founded
- MGRC 1979
- ARWR 2003
- Country
- MGRC United States
- ARWR United States
- Employees
- MGRC N/A
- ARWR N/A
- Industry
- MGRC Diversified Commercial Services
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- MGRC Consumer Discretionary
- ARWR Health Care
- Exchange
- MGRC Nasdaq
- ARWR Nasdaq
- Market Cap
- MGRC 3.0B
- ARWR 2.4B
- IPO Year
- MGRC N/A
- ARWR 1993
- Fundamental
- Price
- MGRC $118.28
- ARWR $19.56
- Analyst Decision
- MGRC Buy
- ARWR Buy
- Analyst Count
- MGRC 2
- ARWR 11
- Target Price
- MGRC $145.50
- ARWR $43.33
- AVG Volume (30 Days)
- MGRC 116.0K
- ARWR 1.5M
- Earning Date
- MGRC 02-19-2025
- ARWR 02-04-2025
- Dividend Yield
- MGRC 1.61%
- ARWR N/A
- EPS Growth
- MGRC 23.19
- ARWR N/A
- EPS
- MGRC 9.15
- ARWR N/A
- Revenue
- MGRC $888,783,000.00
- ARWR $3,551,000.00
- Revenue This Year
- MGRC $12.09
- ARWR $3,402.96
- Revenue Next Year
- MGRC $1.26
- ARWR $123.96
- P/E Ratio
- MGRC $12.93
- ARWR N/A
- Revenue Growth
- MGRC 12.06
- ARWR N/A
- 52 Week Low
- MGRC $95.50
- ARWR $17.05
- 52 Week High
- MGRC $130.86
- ARWR $36.72
- Technical
- Relative Strength Index (RSI)
- MGRC 61.30
- ARWR 47.89
- Support Level
- MGRC $109.98
- ARWR $17.75
- Resistance Level
- MGRC $111.80
- ARWR $19.19
- Average True Range (ATR)
- MGRC 2.59
- ARWR 1.04
- MACD
- MGRC 1.04
- ARWR 0.04
- Stochastic Oscillator
- MGRC 89.69
- ARWR 59.74
About MGRC McGrath RentCorp
McGrath RentCorp is a rental company. It is comprised of four reportable business segments: Modular building and portable storage segment (Mobile Modular), Electronic test equipment segment (TRS-RenTelco), Containment solutions for the storage of hazardous and non-hazardous liquids and solids segment (Adler Tanks) and Classroom manufacturing division selling modular classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.